# Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors

> **NCT00216814** · — · TERMINATED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 220 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00216814
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 220 (ACTUAL)
- **Why stopped:** No funding and data was not appropriate to consider continuing.
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216814, "Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00216814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*